Contact-Force-Sensing-Based Radiofrequency Catheter Ablation in Paroxysmal Supraventricular Tachycardias (COBRA-PATH): a randomized controlled trial

Geczy, Tamas; Ramdat Misier, Nawin L.; Szili-Torok, Tamas

doi:10.1186/s13063-020-4219-1

Trials

Table 1 Clinical studies on catheter ablations with contact force (CF)-sensing catheters in patients with atrial fibrillation

From: Contact-Force-Sensing-Based Radiofrequency Catheter Ablation in Paroxysmal Supraventricular Tachycardias (COBRA-PATH): a randomized controlled trial

Study	Year	Type of study	Number of patients		Follow-up (months)	Ablation	CF catheter
Study	Year	Type of study	CF	Control	Follow-up (months)	Ablation	CF catheter
Martinek et al. [4]	2012	Prospective nonrandomized study	25	25	n/a	Circumferential PVI	ThermoCool SmartTouch
Kuck et al. [5] (TOCCATA)	2012	Prospective nonrandomized study	72	n/a	12	Circumferential PVI Right-sided SVT ablation	TactiCath
Reddy et al. [6] (TOCCATA)	2012	Prospective nonrandomized study	32	n/a	12	Circumferential PVI	TactiCath
Neuzil et al. [7] (EFFICAS I)	2013	Prospective nonrandomized study	46	n/a	3	Circumferential PVI plus remapping at 3 months	TactiCath
Casella et al. [8]	2014	Randomized controlled trial	20	35	12	Circumferential PVI	TactiCath or Contact Therapy Cool Path
Andrade et al. [9]	2014	Prospective nonrandomized study	25	50	13.3	Circumferential PVI	ThermoCool SmartTouch
Kimura et al. [10]	2014	Randomized controlled trial	19	19	6.7	Circumferential PVI	ThermoCool SmartTouch
Marijon et al. [11]	2014	Prospective nonrandomized study	30	30	12	Circumferential PVI	ThermoCool SmartTouch
Natale et al. [12] (SMART AF)	2014	Prospective nonrandomized study	161	n/a	6	Circumferential PVI plus possible linear ablations and CFAE. CTI line if patient with AFL	ThermoCool SmartTouch
Sciarra et al. [13]	2014	Prospective nonrandomized study	21	21	2.5	Circumferential PVI	ThermoCool SmartTouch
Wakili et al. [14]	2014	Prospective nonrandomized study	32	35	12	Circumferential PVI	TactiCath
Wutzler et al. [15]	2014	Prospective nonrandomized study	31	112	12	Circumferential PVI	TactiCath
Jarman et al. [16]	2015	Retrospective case–control study	200	400	11.4	PVI^a	ThermoCool SmartTouch
Ullah et al. [1]	2014	Prospective nonrandomized study	50	50	12	PVI or WACA plus CTI plus mitral isthmus plus roof line^b	ThermoCool SmartTouch
Kautzner et al. [17] (EFFICAS II)	2015	Prospective nonrandomized study	24	26 patients from EFFICAS I	3	Circumferential PVI plus remapping at 3 months	TactiCath
Sigmund et al. [18]	2015	Prospective case-matched control trial	99	99	12	Circumferential PVI plus linear ablation plus CFAE^c	ThermoCool SmartTouch
Reddy et al. [19] (TOCCA-STAR)	2015	Randomized controlled trial	146	134	12	Circumferential PVI plus possible linear ablations and CFAE. CTI line if patient with AFL	TactiCath

^aFor paroxysmal atrial fibrillation (AF), additional linear ablation was performed only exceptionally; nonparoxysmal AF, use of additional lesions varied by operator, including linear lesions at the roof, mitral isthmus, posterior wall and CTI, targeting of complex fractionated electrograms, and ablation at the endocardial and epicardial aspects of the coronary sinus
^bCTI line added in patients with AFL hx; if remained in AF, linear lesions added at mitral isthmus and roof, both point-to-point and drag
^cPVI only, PVI with lines, PVI with lines and CFAE, and PVI with CFAE
AFL atrial flutter, hx history n/a not applicable, PVI pulmonary vein isolation, SVT supraventricular tachycardia, CTI cavotricuspid isthmus isolation, CFAE Complex Fractionated Atrial Electrograms, WACA wide antral circumferential ablation

Back to article page

ISSN: 1745-6215

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com